This drug was well tolerated, with a good tolerability profile and few adverse events with oral administration. There were no severe adverse drug events recorded in the study.
Clinical trials assessing ivermectin tablets for the prevention or.
Ivermectin and covid clinical trials. Ahmed s, karim mm, ross ag, et al. The sag and the therapeutics working group will continue to monitor and assess new evidence on ivermectin as it is published. Larger trials will be needed to confirm these preliminary findings.
Most compared ivermectin with placebo or no ivermectin; Actual primary completion date : Two groups, the study group and the control group, took part in the study.
Therefore, this protocol describes a systematic review for assessing the efficacy. Actual study completion date : Actual study start date :
Estimated primary completion date : Preprint posted october 27, 2020.